Celyad SA (CYAD) Announces Presentation of Encouraging NKR-2 Phase I Data at ASH 2016
Tweet Send to a Friend
Celyad (Nasdaq: CYAD) announces that first data analysis of the NKR-2 Phase I trial shows encouraging results which will be ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE